Tuberculosis Vaccine Treatment Market Revenue 2024 to 2034
Tuberculosis Vaccine Treatment Market Revenue 2024 to 2034
The tuberculosis vaccine treatment market, valued at USD 0.97 billion in 2024, will grow to USD 1.44 billion by 2034 at 4.05% CAGR, driven by ongoing global TB control programs and vaccine development.
Report ID: 10468
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 0.97 Bn
Forecast Year,
USD 1.44 Bn
CAGR, 2025 -
4.05%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Tuberculosis Vaccine Treatment Market Size Analysis
Tuberculosis Vaccine Treatment Market Size By Vaccine Type 2024 to 2034 (USD )
| Vaccine Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG | 0.36 | 0.33 | 0.34 | 0.37 | 0.37 | 0.39 | 0.45 | 0.43 | 0.43 | 0.42 | 0.44 |
| Live Attenuated (New Gen) | 0.51 | 0.57 | 0.56 | 0.59 | 0.60 | 0.61 | 0.60 | 0.64 | 0.68 | 0.74 | 0.79 |
| Subunit/Other | 0.10 | 0.11 | 0.16 | 0.13 | 0.17 | 0.18 | 0.18 | 0.21 | 0.22 | 0.23 | 0.21 |
Tuberculosis Vaccine Treatment Market Size By Age Group 2024 to 2034 (USD )
| Age Group | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pediatric | 0.59 | 0.63 | 0.64 | 0.65 | 0.68 | 0.70 | 0.74 | 0.78 | 0.80 | 0.83 | 0.88 |
| Adult | 0.38 | 0.38 | 0.41 | 0.45 | 0.46 | 0.48 | 0.49 | 0.50 | 0.53 | 0.55 | 0.56 |
Tuberculosis Vaccine Treatment Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public Programs | 0.57 | 0.61 | 0.64 | 0.65 | 0.65 | 0.66 | 0.69 | 0.75 | 0.79 | 0.87 | 0.88 |
| Private Clinics/Hospitals | 0.31 | 0.32 | 0.34 | 0.36 | 0.41 | 0.43 | 0.45 | 0.45 | 0.43 | 0.41 | 0.44 |
| NGOs/Non-Profits | 0.09 | 0.07 | 0.08 | 0.08 | 0.08 | 0.10 | 0.09 | 0.08 | 0.11 | 0.11 | 0.12 |
Tuberculosis Vaccine Treatment Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.09 | 0.09 | 0.09 | 0.11 | 0.08 | 0.09 | 0.11 | 0.09 | 0.07 | 0.09 | 0.05 |
| Europe | 0.21 | 0.26 | 0.26 | 0.26 | 0.30 | 0.33 | 0.34 | 0.39 | 0.40 | 0.39 | 0.43 |
| Asia Pacific | 0.24 | 0.25 | 0.32 | 0.33 | 0.37 | 0.41 | 0.40 | 0.45 | 0.49 | 0.55 | 0.58 |
| Latin America | 0.19 | 0.19 | 0.16 | 0.18 | 0.19 | 0.20 | 0.19 | 0.20 | 0.22 | 0.19 | 0.21 |
| Middle East & Africa | 0.24 | 0.22 | 0.21 | 0.22 | 0.19 | 0.16 | 0.18 | 0.16 | 0.16 | 0.18 | 0.17 |
Tuberculosis Vaccine Treatment Market
Tuberculosis Vaccine Treatment Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
